文献速递脑血管病外科功能神经外科

单纯立体定向放射外科与联合栓塞治疗脑动静脉畸形的系统综述与Meta分析

Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations: a systematic review and meta-analysis.
PubMed 文献 · J Neurosurg · 2017-05-12

该系统综述与Meta分析纳入12项研究共1716例脑动静脉畸形患者,比较栓塞联合立体定向放射外科(E+SRS组)与单纯立体定向放射外科(SRS组)的闭塞率。E+SRS组完全闭塞率为48.4%(330/681),SRS组为62.7%(613/978),Meta分析显示E+SRS组闭塞率显著更低(OR 0.51,95%CI 0.41-0.64,p<0.00001)。作者认为该比较未充分校正两组初始AVM特征的差异,需进一步研究。

要点

  • E+SRS组完全闭塞率48.4%(330/681),SRS组62.7%(613/978)。
  • Meta分析显示E+SRS组闭塞率显著低于SRS组(OR 0.51,95%CI 0.41-0.64,p<0.00001)。
  • 作者指出该比较未充分校正两组初始AVM特征差异,需进一步研究。

核心结论

  • 栓塞联合立体定向放射外科治疗脑动静脉畸形的闭塞率低于单纯立体定向放射外科治疗。
  • 该比较未充分校正E+SRS组与SRS组初始AVM特征的差异。
  • 作者认为需进一步研究以解决这些局限性。

研究设计与样本

  • 系统综述与Meta分析,通过PubMed检索文献,纳入报告10例及以上AVM患者且同时提供E+SRS组与SRS组闭塞数据的研 究。
  • 共纳入12篇文章、1716例患者。

主要发现

  • 在具有影像学随访数据的患者中,E+SRS组完全闭塞率为48.4%(330/681),SRS组为62.7%(613/978)。
  • Meta分析显示E+SRS组闭塞率显著低于SRS组(OR 0.51,95%CI 0.41-0.64,p<0.00001)。
  • 症状性放射不良反应发生率E+SRS组为6.6%(27/412例),SRS组为11.1%(48/433例)。
  • SRS后年出血率E+SRS组为2.0%-6.5%,SRS组为0%-2.0%。
  • 永久性致残率E+SRS组为0%-6.7%,SRS组为0%-13.5%。

局限性

  • 该比较未充分校正E+SRS组与SRS组初始AVM特征的差异。
  • 作者认为需进一步研究以解决这些局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Embolization of brain arteriovenous malformations (AVMs) prior to stereotactic radiosurgery (SRS) has been reported to negatively affect obliteration rates. The goal of this systematic review and meta-analysis was to compare the outcomes of AVMs treated with embolization plus SRS (E+SRS group) and those of AVMs treated with SRS alone (SRS group). METHODS A literature review was performed using PubMed to identify studies with 10 or more AVM patients and obliteration data for both E+SRS and SRS groups. A meta-analysis was performed to compare obliteration rates between the E+SRS and SRS groups. RESULTS Twelve articles comprising 1716 patients were eligible for analysis. Among the patients with radiological follow-up data, complete obliteration was achieved in 48.4% of patients (330/681) in the E+SRS group compared with 62.7% of patients (613/978) in the SRS group. A meta-analysis of the pooled data revealed that the obliteration rate was significantly lower in the E+SRS group (OR 0.51, 95% CI 0.41-0.64, p < 0.00001). Symptomatic adverse radiation effects were observed in 6.6% (27/412 patients) and 11.1% (48/433 patients) of the E+SRS and SRS groups, respectively. The annual post-SRS hemorrhage rate was 2.0%-6.5% and 0%-2.0% for the E+SRS and SRS groups, respectively. The rates of permanent morbidity were 0%-6.7% and 0%-13.5% for the E+SRS and SRS groups, respectively. CONCLUSIONS Arteriovenous malformation treatment with combined embolization and SRS is associated with lower obliteration rates than those with SRS treatment alone. However, this comparison does not fully account for differences in the initial AVM characteristics in the E+SRS group as compared with those in the SRS group. Further studies are warranted to address these limitations.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Russell D, Peck T, Ding D, et al. Stereotactic radiosurgery alone or combined with embolization for brain arteriovenous malformations: a systematic review and meta-analysis. J Neurosurg. 2017. PMID: 28498057. doi:10.3171/2016.11.JNS162382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。